Biotech News - Invitrogen Corporation (Public, NASDAQ:IVGN)

Invitrogen Corporation (Public, NASDAQ:IVGN)

Stratagene Ordered to Shell Out Triple the Amount Previously Awarded
in the Invitrogen Lawsuit

In a patent infringement case, a U.S. court awarded Invitrogen $16.2
million in damages.

On July 25, 2006, the jury found that Stratagene had willfully
infringed on Invitrogen's valid 4,981,797 patent by making and selling
its competent E. coli cell products.

http://tech.groups.yahoo.com/group/biotech-news/
http://www.arizonabiotech.com/
http://www.azhttp.com/

http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/

<*> Your email settings:
Individual Email | Traditional

<*> To change settings online go to:
http://groups.yahoo.com/group/biotech-news/join
(Yahoo! ID required)

<*> To change settings via email:
mailto:biotech-news-digest@yahoogroups.com
mailto:biotech-news-fullfeatured@yahoogroups.com

<*> To unsubscribe from this group, send an email to:
biotech-news-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/